“…This finding provides crucial information on the mechanisms controlling survival of diseased granulocytes. Notably, overexpression of activated Akt and downstream Bcl2 cannot increase the lifespan of normal granulocytes (46), but it does in other pathological situations, like sepsis (47). Third, high doses of G-CSF result in the amelioration of dysgranulopoiesis, granulocyte precursor survival defects, as previously shown in iPSC-derived granulopoiesis (21), and of CEBPB expression levels, as shown in primary myelopoiesis from patients (11,48).…”